New study findings indicate that treatment with coenzyme Q10 (CoQ) may
help adults with type 2 diabetes to stabilize blood glucose levels
and
lower their blood pressure.
Previous reports have shown
that CoQ therapy can reduce blood pressure in hypertensive subjects.
However, it was unclear if this effect also occurs in patients with
diabetes.
Reports
have shown that CoQ therapy can reduce blood pressure in hypertensive subjects.
Dr. J.M. Hodgson and
colleagues, from the Royal Perth Hospital in Australia, conclude.
"these results show that coenzyme Q10 supplementation may improve
blood pressure and long-term glycemic control in subjects with type 2
diabetes, but these improvements were not associated with reduced
oxidative stress."
Coenzyme
Q10 supplementation may improve blood pressure and long-term glycemic
control in subjects with type 2 diabetes
The researchers assessed the
outcomes of 74 adults with type 2 diabetes and high cholesterol who were
randomized to receive coenzyme Q10 twice a day, 200 mg of fenofibrate once
daily, both treatments, or neither treatment for 12 weeks. Study
volunteers ranged in age from 31 to 75 years.
Patients who received
coenzyme Q10 alone or in combination with the other supplement lowered
their systolic blood pressure by an average of about 6 mm Hg. Diastolic
blood pressure was reduced by an average of 3 mm Hg. Treatment with CoQ
was also associated with better long-term control of blood sugar.
Treatment with CoQ
was also associated with
better long-term control of blood sugar.
There was no effect of
fenofibrate alone on blood pressure or glucose control, according to the
report.
Source: Diabetes In
Control Dot Com: Eur J Clin Nutr 2002;56:1137-1142.
Therapeutic
Dosage
